DNA Script to Present at the GP-write Scientific Working Meeting

Paris, France, April 27th 2018 - DNA Script, a leader in the field of enzymatic de novo manufacturing of nucleic acids, today announced that Thomas Ybert, Ph.D, chief executive officer, will present at the GP-write Scientific Working Meeting on Tuesday, May 1 at 5:50 p.m. ET in Boston.

Ybert's presentation will provide an overview of the company's business and its industry-leading enzymatic synthesis platform. Ybert will also provide an update on the company's recent progress.

For more information on the GP-write Scientific Working Meeting, please visit: http://engineeringbiologycenter.org/2018meeting/

About DNA Script
Founded in 2014 in Paris, DNA Script is the world's leading company in manufacturing de novo synthetic nucleic acids using an enzymatic technology. The company aims to accelerate innovation in life sciences and technology through rapid, affordable and high-quality DNA synthesis. DNA Script's approach leverages billions of years of natural evolution to enable genome-scale synthesis. The company's technology has the potential to greatly accelerate the development of new therapeutics, sustainable chemical production, improved crops and DNA data storage.

Press contact in the US
Lisa Rodriguez

Press contacts in Europe
Caroline Carmagnol and Tatiana Vieira
06 64 18 99 59 / 01 44 54 36 65

DNA Script Contact
Sylvain Gariel, COO